Podcast

Diabetes Dialogue: April 2022 Edition

Author(s):

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE

In the April 2022 edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini discuss the implications of the FDA's approval of semaglutide 2.0 mg, the use of novel glycemic control metrics, and a preview of ATTD 2022.

Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives is available in an audio-only format on Spotify and Apple Podcasts.

Related Videos
Duloxetine for Patients with COPD Suffering from Comorbid Depression
Enhancing Standards for Ethical Responsibilities within Clinical Research
Jennifer Flemming, MD | Credit: AASLD
Related Content
Credit: Adobe Stock/ Marina Varnava
January 20th 2025

High Pollen Exposure Linked to Increased Chronic Respiratory Mortality

Chelsie Derman
Default thumbnail for The Medical Sisterhood podcast
January 16th 2025

Medical Sisterhood: Polished and Powerful—Women Leading the Charge in Advocacy

Mona Shahriari, MD, FAAD Shadi Kourosh, MD, MPH
Welcome Back to The Respiratory Report
January 20th 2025

Welcome Back to The Respiratory Report

Tim Smith
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes | Image Credit: HCPLive
January 16th 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Stephen Schworer, MD, PhD | Credit: American Lung Association
January 20th 2025

Small Airway Mucus Plugging in Severe Asthma: Insights and Implications

Stephen Schworer, MD, PhD
Joselyn Rojas-Quintero, MSc, MD | Credit: American Lung Association
January 20th 2025

Metabolic Reprograming in Alveolar Epithelial Cells Type 2: Repurposing Old Drugs for Emphysema Treatment

Joselyn Rojas-Quintero, MD
© 2025 MJH Life Sciences

All rights reserved.